[1]
“Comparative Effectiveness and Safety of High-Intensity Statins (Atorvastatin vs Rosuvastatin) in Coronary Heart Disease Patients After Percutaneous Coronary Intervention (PCI) : A Literature Review”, JPS, vol. 9, no. 3, pp. 2815–2826, Aug. 2026, doi: 10.36490/journal-jps.com.v9i3.1676.